Busulphan in the Treatment of Chronic Granulocytic Leukaemia
1961

Busulphan for Chronic Granulocytic Leukaemia Treatment

Sample size: 25 publication Evidence: moderate

Author Information

Author(s): J. M. Bridges, Dorothy M. Hayes, M. G. Nelson

Primary Institution: Royal Victoria Hospital, Belfast

Hypothesis

Can busulphan effectively treat chronic granulocytic leukaemia?

Conclusion

Busulphan therapy resulted in satisfactory responses in the majority of patients, but did not significantly prolong survival.

Supporting Evidence

  • 14 out of 16 patients treated with busulphan as initial therapy achieved satisfactory responses.
  • Patients who had previous radiotherapy and became resistant showed poor responses to busulphan.
  • Maintenance therapy with busulphan resulted in stable haematological and clinical courses for many patients.

Takeaway

Doctors used a medicine called busulphan to help people with a type of blood cancer, and many of them got better, but it didn't help them live longer.

Methodology

Patients were treated with busulphan and monitored for clinical and haematological responses.

Limitations

The study had a small sample size and did not track long-term survival benefits.

Participant Demographics

Patients included 16 males and 9 females, aged 24 to 67 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication